Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RLAY Relay Therapeutics > Detailed Quotes

RLAY Relay Therapeutics

Watchlist
18.345
-0.425-2.26%
Trading Session  12/05 15:57 ET
High
18.950
Open
18.750
Turnover
11.41M
Low
17.980
Pre Close
18.770
Volume
619.49K
Market Cap
2.22B
P/E(TTM)
Loss
52wk High
35.360
Shares
120.89M
P/E(Static)
Loss
52wk Low
12.650
Float Cap
1.59B
Bid/Ask %
27.27%
Historical High
64.370
Shs Float
86.92M
Volume Ratio
0.70
Historical Low
12.650
Dividend TTM
--
Div Yield TTM
--
P/B
2.22
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.71%
Amplitude
5.17%
Avg Price
18.424
Lot Size
1
Float Cap
1.59B
Bid/Ask %
27.27%
Historical High
64.370
Shs Float
86.92M
Volume Ratio
0.70
Historical Low
12.650
Dividend TTM
--
P/B
2.22
Dividend LFY
--
Turnover Ratio
0.71%
Amplitude
5.17%
Avg Price
18.424
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
CEO: Mr. Sanjiv K. Patel, M.D.
Market: NASDAQ
Listing Date: 07/16/2020
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist